Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases.
暂无分享,去创建一个
T. Funahashi | I. Shimomura | S. Fukuda | Y. Obata | H. Nishizawa | N. Maeda | Tomoaki Natsukawa | Shigeki Masuda | Y. Fujishima | J. Murai | H. Nagao | Y. Tanaka | Takayuki Yamada | Fumi Sato | Hideyuki Namazui | Yoshimitsu Tanaka | Yoshinari Obata
[1] T. Funahashi,et al. Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] T. Funahashi,et al. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects , 2016, Cardiovascular Diabetology.
[3] 松田 圭介. Positive Feedback Regulation Between Adiponectin and T-Cadherin Impacts Adiponectin Levels in Tissue and Plasma of Male Mice , 2016 .
[4] K. Awai,et al. Association of epicardial and abdominal visceral adipose tissue with coronary atherosclerosis in patients with a coronary artery calcium score of zero. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[5] Y. Takeishi,et al. Epicardial Adipose Tissue Reflects the Presence of Coronary Artery Disease: Comparison with Abdominal Visceral Adipose Tissue , 2015, BioMed research international.
[6] I. Shimomura,et al. Targeted delivery of adipocytokines into the heart by induced adipocyte cell-sheet transplantation yields immune tolerance and functional recovery in autoimmune-associated myocarditis in rats. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[7] C. Rochitte,et al. Pericardial Fat Is Associated with Coronary Artery Calcification in Non-Dialysis Dependent Chronic Kidney Disease Patients , 2014, PloS one.
[8] P. Arner,et al. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. , 2014, The Journal of clinical endocrinology and metabolism.
[9] Yukiko Nakamura,et al. Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice , 2014, Scientific Reports.
[10] C. Jung,et al. Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus , 2014, Cardiovascular Diabetology.
[11] T. Funahashi,et al. Adiponectin and the cardiometabolic syndrome: an epidemiological perspective. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[12] K. Borch-Johnsen,et al. Fat Distribution and Glucose Intolerance Among Greenland Inuit , 2013, Diabetes Care.
[13] Bruce Bartholow Duncan,et al. Epicardial Fat: Definition, Measurements and Systematic Review of Main Outcomes , 2013, Arquivos brasileiros de cardiologia.
[14] T. Funahashi,et al. Cardiovascular-metabolic impact of adiponectin and aquaporin. , 2013, Endocrine journal.
[15] MichioShimabukuro,et al. Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis , 2013 .
[16] T. Funahashi,et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study) , 2012, Annals of medicine.
[17] Hisashi Yamanaka,et al. Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition , 2011, Nucleosides, nucleotides & nucleic acids.
[18] I. Shimomura,et al. Induced Adipocyte Cell-Sheet Ameliorates Cardiac Dysfunction in a Mouse Myocardial Infarction Model: A Novel Drug Delivery System for Heart Failure , 2011, Circulation.
[19] Udo Hoffmann,et al. Abdominal Subcutaneous and Visceral Adipose Tissue and Insulin Resistance in the Framingham Heart Study , 2010, Obesity.
[20] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[21] A. Malavazos,et al. Pericardial Adipose Tissue, Atherosclerosis, and Cardiovascular Disease Risk Factors: The Jackson Heart Study , 2010, Diabetes Care.
[22] Maximilian Reiser,et al. Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[23] Udo Hoffmann,et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. , 2008, European heart journal.
[24] [Evidence-based practice guideline for the treatment of CKD]. , 2009, Nihon Jinzo Gakkai shi.
[25] Udo Hoffmann,et al. Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.
[26] Udo Hoffmann,et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.
[27] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[28] Y. Matsuzawa. Metabolic syndrome--definition and diagnostic criteria in Japan. , 2005, Journal of atherosclerosis and thrombosis.
[29] F. Leonetti,et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.
[30] S. Kihara,et al. Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[31] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[32] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[33] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[34] S. Yamashita,et al. Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.
[35] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[36] Y. Matsuzawa,et al. Pathophysiology and pathogenesis of visceral fat obesity. , 1995, Annals of the New York Academy of Sciences.
[37] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[38] F. Terry. Human obesity. , 1987, Annals of the New York Academy of Sciences.
[39] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.